Sign in

CIK 0001754068 · Non-accelerated filer<br>Smaller reporting company

Kalaris Therapeutics, Inc.

Sign in to watch
Ticker
KLRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831971007
Phone
650-249-2727
Business address
400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
Former names
Allovir, Inc., ViraCyte, Inc.
  1. CORRESP Other Correspondence Between Filers and SEC Staff
  2. S-4/A Deal Registration Statement - Business Combination
  3. UPLOAD Other SEC-generated Letter
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 144 Insider Sale of Securities
  8. 144 Insider Sale of Securities
  9. 144 Insider Sale of Securities
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. S-4/A Deal Registration Statement - Business Combination
  12. 425 Deal Prospectus/Communication re Business Combination
  13. 8-K Event Shareholder rights changed · Bylaws or fiscal year change
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 144 Insider Sale of Securities
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 425 Deal Prospectus/Communication re Business Combination

Page 7 of 36 · 701 filings